FDA Clinical Trial Oversight: Agency Must Ensure “System Is Not Broken”
Executive Summary
FDA needs to demonstrate to the public that the "clinical trial system is not broken," Associate Commissioner Murray Lumpkin, MD, told the American Association of Pharmaceutical Scientists' annual meeting in Toronto Nov. 11
You may also be interested in...
FDA Clinical Trials To Get External Audits; Investigation Of Diet Study Pending
FDA plans to initiate routine outside audits of the agency's clinical research
FDA Clinical Trials To Get External Audits; Investigation Of Diet Study Pending
FDA plans to initiate routine outside audits of the agency's clinical research
HHS Human Research Protections Office Gains FDA Science Advisor Schwetz
HHS Office for Human Research Protections Acting Director Bernard Schwetz, PhD, will facilitate coordination between HHS and FDA on human subject protection activities